Conferences can be an excellent way to connect with fellow oncologists and stay informed on the latest research. These events are key to providing quality, up-to-date patient care. Below is a ...

Caring for someone with multiple myeloma can be challenging on many levels. The person who has just been diagnosed may look to you for information to help them better understand the disease to ...

Biologic heterogeneity in myeloma supports subtype-specific approaches, and t(4;14) defines a clinically meaningful subset with distinct pathway activation and historically aggressive behavior.

Objective To identify risk factors for pulmonary infection during chemotherapy in Multiple Myeloma (MM) patients and construct a nomogram prediction model. Methods A total of 171 MM patients admitted ...

Reinaldo Cortes-Quantip has undergraduate studies in Mass Communication and Media Studies, and master’s degree in Political Science from the University of the Andes, Venezuela. Prior his doctoral ...

New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments. Once a dire ...

SAN ANTONIO – Bexar County Court at Law Judge Rosie Speedlin Gonzalez was indicted Thursday, more than a year after investigators said she had an attorney handcuffed during a dispute in her courtroom.

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple myeloma treatment paradigm, the drug is still finding ways to consolidate its ...

Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth ...

Daratumumab and hyaluronidase-fihj is now FDA-approved for newly diagnosed multiple myeloma patients ineligible for ASCT, in combination with VRd. The phase 3 CEPHEUS trial showed significant ...

Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II) For over half a ...